(Q72684559)

English

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

scientific article published on 01 July 1994

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

based on heuristic

inferred from title

author name string

A P Greening

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

P W Ind

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

M Northfield

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

G Shaw

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

0 references

publication date

1 July 1994

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

344

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

8917

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

219-224

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Differences in hospital asthma management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines on the management of asthma. Statement by the British Thoracic Society, the Brit. Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal Colle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2992996-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(94)92996-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7913155%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72684559&oldid=1939420697"